Fettstoffwechselstörungen in der Schwangerschaft

Schlüsselwörter

Fettstoffwechsel - Schwangerschaft - Cholesterin

Key words

Lipid disorder - pregnancy - cholesterol

Literatur

• 1 Durrington P. Dyslipidaemia.  Lancet. 2003;  362 717-731
• 2 Hosokawa A, Bar-Oz B, Ito S. Use of lipid-lowering agents (statins) during pregnancy.  Can Fam Physician. 2003;  49 747-749
• 3 Knopp R H, Bergelin R O, Wahl P W, Walden C E, Chapman M, Irvine S. Population-based lipoprotein lipid reference values for pregnant women compared to nonpregnant women classified by sex hormone usage.  Am J Obstet Gynecol. 1982;  143 626-637
• 4 Lammert F, Matern S. Stoffwechselerkrankungen. In: Rath W, Friese K Erkrankungen in der Schwangerschaft. Stuttgart; Georg Thieme Verlag 2005: 321-331
• 5 LaRosa J C. Dyslipoproteinämien bei Frauen.  In: Schwandt P, Richter WO, Parhofer KG Handbuch der Fettstoffwechselstörungen. Dyslipoproteinämien und Atherosklerose: Pathophysiologie, Diagnostik und Therapie. Stuttgart; Schattauer 2006
• 6 Laufs U, Hamm C W, Böhm M. Statintherapie bei koronarer Herzkrankheit.  Dtsch Ärztebl. 2006;  103 B2356-B2360
• 7 Montes A, Walden C E, Knopp R H, Cheung M, Chapman M B, Albers J J. Physiologic and supraphysiologic increases in lipids and apoproteins in late pregnancy and post partum. Possible markers for the diagnosis of „prelipemia”.  Arteriosclerosis. 1987;  4 407-417
• 8 Napoli C, D’Armiento F P, Mancini F P, Postiglione A, Witztum J L, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.  J Clin Invest. 1997;  100 2680-2690
• 9 Napoli C, Glass C K, Witzum J L, Deutsch R, D’Armiento F P, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.  Lancet. 1999;  354 1234-1241
• 10 National Cholesterol Education Program Expert Panel (Hrsg.) .Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda; National Heart, Lung, and Blood Institute, National Institutes of Health 2002
• 11 Stamler J, Wentworth D, Neaton J. for the MRFIT Research Group . Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).  JAMA. 1986;  256 2823-2828
• 12 Thadhani R, Stampfer M J, Hunter D J, Manson J E, Solomon C G, Curhan G C. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy.  Obstet Gynecol. 1999;  94 543-550
• 13 Van den Elzen H J, Wladimiroff J W, Cohen-Overbeek T E, de Bruijn A J, Grobbee D E. Serum lipids in early pregnancy and the risk of pre-eclampsia.  Br J Obstet Gynaecol. 1996;  103 117-122